{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:40:14Z","timestamp":1780486814519,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,12]]},"DOI":"10.7759\/cureus.23104","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T19:29:25Z","timestamp":1647113365000},"source":"Crossref","is-referenced-by-count":5,"title":["Successful Use of Dupilumab as a Salvage Therapy for Recalcitrant Allergic Fungal Rhinosinusitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Revan A","family":"Mujahed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A","family":"Marglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama S","family":"Maksood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talah A","family":"Felemban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.06.023","article-title":"Allergic fungal rhinosinusitis","volume":"142","author":"Dykewicz MS","year":"2018","unstructured":"Dykewicz MS, Rodrigues JM, Slavin RG. Allergic fungal rhinosinusitis. J Allergy Clin Immunol. 2018, 142:341-51. 10.1016\/j.jaci.2018.06.023","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens WJ","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al.. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020, 58:1-464. 10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-013-2449-5","article-title":"The prevalence of allergic fungal rhinosinusitis in sinonasal polyposis","volume":"270","author":"Bakhshaee M","year":"2013","unstructured":"Bakhshaee M, Fereidouni M, Mohajer MN, Majidi MR, Azad FJ, Moghiman T. The prevalence of allergic fungal rhinosinusitis in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2013, 270:3095-8. 10.1007\/s00405-013-2449-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9546453","article-title":"Recurrence pattern and complication rate of allergic fungal sinusitis: a 10-year tertiary center experience","volume":"2020","author":"Alghonaim Y","year":"2020","unstructured":"Alghonaim Y, Alfayez A, Alhedaithy R, Alsheikh A, Almalki M. Recurrence pattern and complication rate of allergic fungal sinusitis: a 10-year tertiary center experience. Int J Otolaryngol. 2020, 2020:10.1155\/2020\/9546453","journal-title":"Int J Otolaryngol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2009.212","article-title":"Prevalence of allergic fungal sinusitis among patients with nasal polyps","volume":"29","author":"Telmesani LM","year":"2009","unstructured":"Telmesani LM. Prevalence of allergic fungal sinusitis among patients with nasal polyps. Ann Saudi Med. 2009, 29:212-4. 10.5144\/0256-4947.2009.212","journal-title":"Ann Saudi Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802314809","article-title":"Allergic fungal sinusitis: pathophysiology, diagnosis and management","volume":"47","author":"Schubert MS","year":"2009","unstructured":"Schubert MS. Allergic fungal sinusitis: pathophysiology, diagnosis and management. Med Mycol. 2009, 47:324-30. 10.1080\/13693780802314809","journal-title":"Med Mycol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.03.010","article-title":"Allergic fungal rhinosinusitis","volume":"4","author":"Hoyt AE","year":"2016","unstructured":"Hoyt AE, Borish L, Gurrola J, Payne S. Allergic fungal rhinosinusitis. J Allergy Clin Immunol Pract. 2016, 4:599-604. 10.1016\/j.jaip.2016.03.010","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myu037","article-title":"Quality of life, disability scores, and distress index in fungal rhinosinusitis","volume":"52","author":"Srivastava RM","year":"2014","unstructured":"Srivastava RM, Rijuneeta, Gupta AK, Patro SK, Avasthi A. Quality of life, disability scores, and distress index in fungal rhinosinusitis. Med Mycol. 2014, 52:706-14. 10.1093\/mmy\/myu037","journal-title":"Med Mycol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008263.pub2","article-title":"Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis","author":"Sacks PL","year":"2011","unstructured":"Sacks PL, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev. 2011, 10.1002\/14651858.CD008263.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial","volume":"156","author":"Simpson EL","year":"2020","unstructured":"Simpson EL, Paller AS, Siegfried EC, et al.. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial. JAMA Dermatol. 2020, 156:44-56. 10.1001\/jamadermatol.2019.3336","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro M","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, et al.. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018, 378:2486-96. 10.1056\/NEJMoa1804092","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano I","year":"2020","unstructured":"Hirano I, Dellon ES, Hamilton JD, et al.. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology. 2020, 158:111-22. 10.1053\/j.gastro.2019.09.042","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.07.014","article-title":"Dupilumab use in recalcitrant allergic fungal rhinosinusitis","volume":"125","author":"Lo RM","year":"2020","unstructured":"Lo RM, Liu AY, Valdez TA, Gernez Y. Dupilumab use in recalcitrant allergic fungal rhinosinusitis. Ann Allergy Asthma Immunol. 2020, 125:617-9. 10.1016\/j.anai.2020.07.014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref14","unstructured":"FDA approves first treatment for chronic rhinosinusitis with nasal polyps. (2019). Accessed. January 10, 2021: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-chronic-rhinosinusitis-nasal-polyps."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.106479","article-title":"A case report of allergic fungal rhinosinusitis managed with dupilumab","volume":"88","author":"Alotaibi NH","year":"2021","unstructured":"Alotaibi NH, Aljasser LA, Arnaout RK, Alsomaili S. A case report of allergic fungal rhinosinusitis managed with dupilumab. Int J Surg Case Rep. 2021, 88:10.1016\/j.ijscr.2021.106479","journal-title":"Int J Surg Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0191","article-title":"Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis","volume":"12","author":"Boyle JV","year":"2020","unstructured":"Boyle JV, Lam K, Han JK. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis. Immunotherapy. 2020, 12:111-21. 10.2217\/imt-2019-0191","journal-title":"Immunotherapy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens WJ","year":"2019","unstructured":"Fokkens WJ, Lund V, Bachert C, et al.. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019, 74:2312-9. 10.1111\/all.13875","journal-title":"Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89078-successful-use-of-dupilumab-as-a-salvage-therapy-for-recalcitrant-allergic-fungal-rhinosinusitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:56Z","timestamp":1707507476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89078-successful-use-of-dupilumab-as-a-salvage-therapy-for-recalcitrant-allergic-fungal-rhinosinusitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,12]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.23104","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,12]]}}}